Skip to content
Clinical Trials – home

Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z o.o.

Verified siteinfo

Poland Ul. Marcelinska 92, 60-324 Poznan, Poland

  • 25 trials recruiting
  • Crohn's disease · Colitis ulcerative · Psoriatic arthropathy
  • Adults and children

About Specializations

Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z o.o. in Poznan, Poland specialises in clinical trials of conditions such as Crohn's disease, Colitis ulcerative, Psoriatic arthropathy, Systemic lupus erythematosus, and other specialisations. This site conducts important research.

Main research areas of the site

Gastroenterology

The medical center is at the forefront of gastroenterology research, focusing on innovative treatments for inflammatory bowel diseases.

  • Crohn's Disease
  • Ulcerative Colitis

Through cutting-edge clinical trials, the center is advancing the understanding of disease mechanisms and developing new therapeutic strategies to improve patient outcomes.

Rheumatology

Specializing in rheumatology, the center conducts extensive research on autoimmune conditions, aiming to enhance treatment efficacy and patient quality of life.

  • Rheumatoid Arthritis
  • Psoriatic Arthritis

By exploring novel biologics and biosimilars, the center contributes significantly to the development of personalized medicine approaches in rheumatology.

Dermatology

The center's dermatology research focuses on chronic skin conditions, aiming to discover effective long-term treatments.

  • Acne Vulgaris
  • Hidradenitis Suppurativa

Innovative topical and systemic therapies are being evaluated to provide relief and improve the quality of life for patients with persistent dermatological issues.

Immunology

In the field of immunology, the center is dedicated to understanding and treating complex autoimmune diseases through advanced research.

  • Systemic Lupus Erythematosus (SLE)
  • Sjögren’s Disease

By investigating the underlying immune mechanisms, the center is paving the way for innovative therapies that target specific pathways involved in these conditions.

Pulmonology

The center's pulmonology research is focused on interstitial lung diseases, particularly those associated with systemic conditions.

  • Systemic Sclerosis Associated with Interstitial Lung Disease

Through comprehensive clinical trials, the center is working to improve diagnostic and therapeutic approaches, enhancing patient care and outcomes in this challenging field.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Marcelinska 9260-324 PoznanPoland
Recruiting now
25 trials
Conditions studied
31
Partner status
Verified site

More sites in PoznanPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

69 clinical trials

Obesity+1

Recruiting

Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Diabetes mellitus+2

Recruiting

A Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Eczema nummular

Recruiting

A study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.

Crohn's disease

Recruiting

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Crohn's disease

Recruiting

Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:MORF-057
  • Sponsor:Morphic Therapeutic Inc.

Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.